Biotechnology company Geron Corp. said Friday it hopes to pave the way for restarting human studies on a potential stem-cell treatment for spinal cord injury by conducting additional preclinical studies.
LANSING – A year ago, the most intense campaign in Michigan was not the race for the presidency but the battle over whether to change the state constitution to allow research using stem cells taken from human embryos created in fertility clinics …
LAS VEGAS — A Murphy Analytics report and profile featuring BrainStorm and detailing its achievements in stem cell research has been released. This report is of potential interest to investors of leading stem cell equities Geron , Osiris Therapeutics , Aastrom Biosciences and StemCells .
Over at the Knight Science Tracker , Charlie Petit has a round-up on news coverage of the California Institute for Regenerative Medicine’s first significant research grants for stem cell research. Though much of the focus in California and nationally has obviously been on the promise of embryonic stem cell research, only four of the 14 funded projects involve these type of stem cells. The …
U.S. District Judge Royce Lamberth on Tuesday dismissed a lawsuit challenging the Obama administration’s move this year to ease federal restrictions on embryonic stem cell research, the AP/Seattle Times reports. In its lawsuit, Nightlight Christian Adoptions alleged that the new federal guidelines would reduce the availability of human embryos for adoptions.
The recent creation of live mice from induced pluripotent stem cells (iPSCs) not only represents a remarkable scientific achievement, but also raises important issues, according to bioethicists at The Johns Hopkins University’s Berman Institute of Bioethics. In a letter published Oct. 28 in Regenerative Medicine, the authors advocate for clear ethical oversight of this research and pose key questions that warrant careful consideration.
Black Sabbath guitarist Tony Iommi is undergoing stem cell treatment after repetitive strain injury left him struggling to play his famous riffs.
The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.
The Salk Institute has been awarded a $10.8 million grant by the California Institute for Regenerative Medicine (CIRM) for translational research focusing on developing a novel stem-cell based therapy for Amyotrophic Lateral Sclerosis (ALS) – or Lou Gehrig’s Disease. Sam Pfaff, Ph.D.
Lansing — Embryonic stem cell research supporters are worried legislation debated in a state Senate committee Wednesday could threaten the progress of research in Michigan. The bills discussed in the Senate Health Policy Committee would establish …